Prof. Giuseppe Lippi, MD
Prof. Giuseppe Lippi was born in Padova (Italy) on October the 4th, 1967. He has taken the degree in Medicine in 1986 and the specialization in Clinical Biochemistry and Laboratory Medicine in 1992. He currently serves as Full Professor of Clinical Biochemistry at the University of Verona (Italy) and director of the clinical chemistry and haematology laboratories of the University Hospital of Verona (Italy).
As regards the scientific activity, he has published more than 1900 articles in peer-reviewed journals, his total Impact Factor is nearly 9000 and the Hirsch Index (H-index) is 113. He has participated to more than 600 national and international congresses and has given more than 300 lectures to national and international meetings. He has been awarded with the 2014 Management Sciences and Patient Safety Division Award of the American Association for Clinical Chemistry (AACC) for outstanding contributions in the field of patient safety in the clinical laboratory/healthcare industry and with the Outstanding Speaker Award from the AACC in 2016. Giuseppe Lippi is also Associate Editor of Clinical Chemistry and Laboratory Medicine and Seminars in Thrombosis and Hemostasis, Chair of the IFCC Task Force on COVID-19, Secretary of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and member of the EFLM working group on preanalytical variability.
The main areas of research include pre-analytical variability, analytical and clinical validation of biomarkers, metabolism of lipoproteins and relevant assay methods, diagnosis and management of disorders of haemostasis and thrombosis, COVID-19.